| Date Filed | Type | Description |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 3,843 shares
@ $1.7468, valued at
$6.7k
Sold 7,449 shares
@ $1.706, valued at
$12.7k
|
|
| 01/04/2023 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 876 shares
@ $1.694, valued at
$1.5k
|
|
| 01/18/2022 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 2,121 shares
@ $3.1918, valued at
$6.8k
|
|
| 01/13/2022 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 2,110,608 options to buy
@ $0
Granted 471,360 options to buy
@ $0 |
|
| 01/13/2022 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 3,770 shares
@ $3.5567, valued at
$13.4k
Sold 854 shares
@ $3.5441, valued at
$3k
|
|
| 01/05/2022 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 849 shares
@ $4.0642, valued at
$3.5k
|
|
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2020 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 201,600 options to buy
@ $0
Granted 135,600 options to buy
@ $0 |
|
| 01/15/2020 |
4
| Norry Elliot (Chief Medical Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 911 shares
@ $5.1347, valued at
$4.7k
|
|
| 01/13/2020 |
3
| Norry Elliot (Chief Medical Officer) has filed a Form 3 on Adaptimmune Therapeutics PLC |